Beta Carotene Linked With Decreased Adenoma Recurrence In Nonsmokers
This article was originally published in The Tan Sheet
Executive Summary
Beta carotene supplementation helps prevent colorectal adenoma recurrence in patients that do not smoke or consume high levels of alcohol, according to a study in the May 21 Journal of the National Cancer Institute
You may also be interested in...
FDA Keeps Door Open To Help Observational Studies Work For Health Claims
FDA says in a final guidance that observational studies alone are insufficient support for health claims, but the agency also says it is interested in making it easier for those studies to support claims
Antioxidants/Cancer Health Claim Contradicted By ATBC Study - FDA
Analyses from the 1994 Alpha-Tocopherol, Beta Carotene intervention trial raise "serious questions" about vitamin E's role in modifying cancer risk, FDA's Center for Food Safety & Applied Nutrition concludes May 4 in rejecting an antioxidant vitamins/cancer health claim.
CARET trial subgroup data suggest lung cancer link to alcohol use among smokers.
BETA CAROTENE LINK TO LUNG CANCER MAY BE INFLUENCED BY ALCOHOL CONSUMPTION among smokers, suggests a new analysis of the Beta Carotene and Retinol Efficacy Trial (CARET) published in the Nov. 6 issue of the Journal of the National Cancer Institute. CARET, a six-center chemoprevention trial, was halted 21 months early because of interim data showing evidence of no benefit and possible harm in participants taking beta carotene (30 mg) and vitamin A (25,000 IU) daily for an average of four years ("The Tan Sheet" Jan. 22, p. 4). The study found 28% more lung cancers and 17% more deaths in the supplement group compared to the placebo group.